According to The Insight Partners' research, the North America gelatin market was valued at US$ 975.65 million in 2024 and is expected to reach US$ 1,328.24 million by 2031, registering a CAGR of 4.5% from 2025 to 2031. Rise in demand from pharmaceutical and nutraceutical industry and rising demand for fortified food and beverages are among the critical factors attributed to the North America gelatin market expansion.
Gelatin, a protein derived from collagen, is highly valued for its biocompatibility, biodegradability, and gelling properties, making it a critical ingredient in drug and supplement formulations. In the pharmaceutical industry, gelatin is widely used to manufacture hard and soft gelatin capsules, which serve as an efficient and stable drug delivery system. In May 2022, Rousselot, Darling Ingredients' health brand and the global leader of collagen-based solutions, launched Quali-Pure HGP 2000, a new endotoxin-controlled, pharmaceutical-grade gelatin designed for vaccines and wound healing applications. These capsules protect sensitive active pharmaceutical ingredients (API) from environmental degradation and ensure targeted delivery within the body. With the rising prevalence of chronic conditions such as cardiovascular diseases, diabetes, and arthritis, the demand for oral dosage forms has surged, thereby boosting gelatin consumption. The rising prevalence of chronic diseases, coupled with an aging global population, drives the growth of the pharmaceutical market. This increased demand for medications translates into a greater need for excipients such as gelatin.
The nutraceutical industry is witnessing rapid growth due to increasing health awareness and growing consumer preference for preventive healthcare. Gelatin plays a crucial role in the production of dietary supplements, including collagen supplements and vitamin capsules. Its functional properties such as high protein content, easy digestibility, and ability to improve joint and bone health, make it a popular choice among aging populations and fitness enthusiasts. In October 2023, Gelita launched a pharmaceutical-grade gelatin, Easyseal, for reliable softgel seams and a new PeptENDURE collagen peptide. According to Gelita, Easyseal will reduce leakers for softgel manufacturers while having lower processing costs and higher quality end products. According to the company, PeptENDURE is designed for endurance sports and is changing the face of competitive race preparation. The trend of clean-label further supports the demand for bovine and porcine-derived gelatin in nutraceutical formulations. Thus, the growing demand from the pharmaceutical & nutraceutical industry is driving the gelatin market.
On the contrary, availability of substitutes hampers the growth of North America gelatin market.
Based on source, the North America gelatin market is segmented into bovine, porcine, poultry, marine, and others. The porcine segment held 49.6% share of the North America gelatin market in 2024, amassing US$ 483.46 million. It is projected to garner US$ 662.94 million by 2031 to expand at 4.6% CAGR during 2024-2031.
By application, the North America gelatin market is segmented into food and beverages, pharmaceuticals and nutraceuticals, personal care and cosmetics, and others. The food and beverages segment held 56.3% share of the North America gelatin market in 2024, amassing US$ 549.29 million. It is projected to garner US$ 738.33 million by 2031 to expand at 4.3% CAGR during 2024-2031.
By country, the North America gelatin market is categorized into the US, Canada, and Mexico. The US held 77.3% share of North America gelatin market in 2024, amassing US$ 754.28 million. It is projected to garner US$ 1,018.31 million by 2031 to expand at 4.4% CAGR during 2024-2031.
Key players operating in the gelatin market are GELITA AG; Nitta Gelatin Inc; ITALGEL S.r.l.; Trobas Gelatine B.V; Jellice Pioneer Europe B.V; Halavet Food Industry and Trade Inc.; Foodmate Co Ltd; Henan E-King Gelatin Co., Ltd; BDF Natural Ingredients SL; Weishardt Holding SA; Darling Ingredients Inc; Lapi Gelatine SpA; Ewald-Gelatine GmbH; Nippi Inc; and Tessenderlo Group NV, among others.
Contact Us
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com